Portfolio company
ShanX
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
ShanX Medtech develops in-vitro diagnostic platforms for rapid antibiotic susceptibility testing to help clinicians treat bacterial infections in point-of-care and laboratory settings.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
iFAST Diagnositcs
The company develops rapid antimicrobial susceptibility testing systems for hospitals and clinical laboratories to identify effective antibiotic treatments for bacterial infections.
SoundCell
SoundCell develops graphene-based biosensor platforms for rapid antibiotic susceptibility testing to help healthcare professionals and diagnostic laboratories identify effective treatments for bacterial infections.
iFAST
iFAST Diagnostics develops rapid antimicrobial susceptibility testing systems for hospital laboratories to identify effective antibiotics for treating bacterial infections.
Resistell
This company develops nanomotion-based diagnostic platforms for rapid antibiotic susceptibility testing to help healthcare providers and laboratories treat bloodstream infections.
Pattern Biosciences
This company develops single-cell microbiology diagnostic systems for rapid bacterial identification and antibiotic susceptibility testing for clinical laboratories and hospital settings.
Astratus
Astratus develops rapid microfluidic diagnostic tests and prototype instrument readers for antimicrobial susceptibility testing in human and veterinary clinical laboratories.
Rapidemic
Rapidemic develops molecular point-of-care diagnostic tests for sexually transmitted infections, providing results for patients and clinicians without requiring laboratory infrastructure or external power.
Deepull
Deepull develops automated diagnostic systems that identify pathogens and antibiotic resistance directly from blood samples for healthcare providers treating sepsis and acute infections.
